More than two decades ago, Adell et al. proposed p53 as an indicator for the effect of preoperative radiotherapy (RT) of rectal cancer using data from the Southeast Swedish Health Care region included in the Swedish rectal cancer trial between 1987–1990 [38]. This evidence concerns the gene TP53 and rectal cancer.